IBUPROFEN-SUSPENSION

Patent europeic · EP1513499 · Stritgà

Inscripziun en il register

Numer da publicaziun
EP1513499
Numer da la dumonda
EP03737116
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
Stritgà
Scrittira da patent
Concedì
Annunzià
17-06-2003
Publitgà
16-03-2005
Concedì
18-01-2012
Stritgà
30-06-2012
Motiv
Taxa annuala betg pajada
Classas IPC
A61K 9/10 (2006.01)
A61K 31/192 (2006.01)
Prioritad
US 388734 P 17.06.2002
Dumonda PCT
PCT/US2003/018922 17.06.2003
Publicaziun PCT
WO2003/105804 24.12.2003
Lingua da l’annunzia
englais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 23-01-2013

    Stritgà, taxa betg pajada

    Published in Swissreg on 23.01.2013

  2. 18-01-2012

    Concedì

    Published in Swissreg on 18.01.2012

Partidas

Possessur

Taro Pharmaceuticals U.S.A., Inc.

TARO PHARMACEUTICALS U.S.A., INC.

Five Skyline Drive, Hawthorne, NY 10532, US

Inventur

GAO, Shen

Brampton, Ontario L6P 1B6, CA

MOROS, Daniel

Larchmont, NY 10538, US

MOLDENHAUER, Maxine

Acton, Ontario L7J 2L7, CA

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.